Potential Role of Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients: Impact of Ferretin and D -Dimer.
Condition(s):Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 PatientsLast Updated:October 12, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 PatientsLast Updated:October 12, 2023Recruiting
Condition(s):Periodontal Diseases; Coronary Artery DiseaseLast Updated:December 3, 2019Unknown status
Condition(s):Gout ArthritisLast Updated:May 12, 2023Recruiting
Condition(s):Metabolic Disease; Periodontal DiseasesLast Updated:January 26, 2021Completed
Condition(s):SepsisLast Updated:June 9, 2022Recruiting
Condition(s):Heart FailureLast Updated:February 17, 2020Unknown status
Condition(s):Early Disease OnsetLast Updated:February 6, 2024Not yet recruiting
Condition(s):Inflammasomes; Cognitive Dysfunction; Pyrin Domain-Containing 3 Protein; Postoperative ComplicationsLast Updated:September 1, 2021Completed
Condition(s):Escherichia Coli Infections; Staphylococcus AureusLast Updated:March 11, 2019Unknown status
Condition(s):OsteoarthritisLast Updated:July 25, 2023Suspended
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.